Mostly, older RA patients are associated with changes in lipid profiles and elevated CV risks, however, juvenile patients with idiopathic arthritic problems reported improvement in lipid profiles after treatment with etanercept (a TNF blocker) [202]. This evidence concerns the gene TNF and rheumatoid arthritis.